Pilocarpine/Tolterodine
- Generic Name
- Pilocarpine/Tolterodine
Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB
Phase 3
Completed
- Conditions
- Overactive Bladder
- Interventions
- Drug: Placebo(For Detrusitol 2mg tablet)Drug: Placebo(For THVD-201)
- First Posted Date
- 2015-06-30
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 384
- Registration Number
- NCT02485067
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
🇰🇷The Catholic University of Korea, Bucheon ST. Mary's Hospital, Seoul, Korea, Republic of
🇰🇷Severance Hospital, Seoul, Korea, Republic of
Effects of Novel Combinations of Tolterodine/Pilocarpine on Pharmacokinetics (PK) and Pharmacodynamics (PD) of Tolterodine in Healthy Subjects
Phase 1
Completed
- Conditions
- Incontinence
- Interventions
- First Posted Date
- 2009-12-21
- Last Posted Date
- 2015-12-30
- Lead Sponsor
- TheraVida, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT01036035
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath